General Information
Version
02/16/2024
Revision date
2024-02-16
Product name
Cisplatin Injection
Product name
Cisplatin Injection
Identification on the label/Trade name
Cisplatin Injection | Manufacturer Fresenius Kabi USA LLC
Manufacturer Name
Fresenius Kabi USA, LLC
Icons in SDS
Company Information
company name
Fresenius Kabi USA, LLC
GHS Information
Signal word
DANGER
Hazard Codes
Hazard statements (CLP)
H300, H314, H317, H318, H334, H350, H361, H362
Hazard statements
Code
Statements
H300
Fatal if swallowed
Section 2
Signal word
DANGER. GHS Class Acute Oral Toxicity. Category 2. Serious Eye Damage. category 1. Skin corrosion. category 1. Respiratory sensitisation. category 1. Carcinogenicity. Category 1B. Reproductive toxicity. Category 2. Skin Sensitization. category 1. Reproductive toxicity. Effects on or via lactation.
Hazard statements
Fatal if swallowed. Causes serious eye damage. Causes severe skin burns and eye damage. May cause allergy or asthma symptoms or breathing difficulties if inhaled. May cause cancer. Suspected of damaging fertility or the unborn child. May cause an allergic skin reaction. May cause harm to breast-fed children.
Precautionary statements
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Do not breathe dust/fume/gas/mist/vapours/spray. Avoid breathing dust/fume/gas/mist/vapours/spray. Avoid contact during pregnancy and while nursing. Wash hands thoroughly after handling. Do not eat, drink or smoke when using this product. Contaminated work clothing should not be allowed out of the workplace. Wear protective gloves/protective clothing/eye protection/face protection. In case of inadequate ventilation wear respiratory protection. IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician IF SWALLOWED: Rinse mouth. Do not induce vomiting. IF ON SKIN: Wash with plenty of water. IF ON SKIN (or hair): Remove/Take off immediately all contaminated clothing. Rinse skin with water/shower. IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. IF exposed or concerned: Get medical advice/attention. Immediately call a POISON CENTER or doctor/physician. Specific treatment (see ... on this label). Rinse mouth. If skin irritation or rash occurs: Get medical advice/attention. If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician. Take off contaminated clothing and wash it before reuse. Wash contaminated clothing before reuse. Store locked up. Dispose of contents/container in accordance with Local, State, Federal and Provincial regulations. Emergency Overview This product is intended for therapeutic use only when prescribed by a physician. Potential adverse reactions from prescribed doses and overdoses are described in the package insert.
Principle Routes of Exposure
Inhalation Ingestion Eye contact Skin Absorption. Injection.
Potential health effects
Eye Contact with eyes may cause irritation. Signs/Symptoms Adverse events from therapeutic doses include: nephrotoxicity, neuropathies, myelosuppression (leukopenia, thrombocytopenia, and anemia), fever, infection, nausea, vomiting, ototoxicity, tinnitis, hearing loss, deafness, and vestibular toxicity. Anaphylactic-like reactions of facial edema, bronchoconstriction, tachycardia, and hypotension have also been reported. Occupational exposure has not been fully investigated. Aggravation of Pre-Existing Individuals with pre-existing renal impairment, myelosuppression, hearing impairment, or previous Conditions history of allergic reaction to cisplatin or other platinumcontaining compounds.